Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?

MLA

Yukihiro Shimizu, et al. “Is There Any Predictor for Hypersensitivity Reactions in Gynecologic Cancer Patients Treated with Paclitaxel-Based Therapy?” Cancer Chemotherapy and Pharmacology, vol. 80, May 2017, pp. 65–69. EBSCOhost, https://doi.org/10.1007/s00280-017-3332-7.

APA

Yukihiro Shimizu, Hidenori Sasa, Kenichi Furuya, Hiroaki Soyama, Yusuke Aizawa, Miki Moriiwa, Masaya Nakatsuka, Hideki Iwahashi, Morikazu Miyamoto, Kento Kato, Hiroki Ishibashi, Tadashi Aoyama, Tomoyuki Yoshikawa, Tomoko Goto, Isao Nagaoka, Yuki Suguchi, Hitoshi Tsuda, Masashi Takano, & Isao Yajima. (2017). Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy? Cancer Chemotherapy and Pharmacology, 80, 65–69. https://doi.org/10.1007/s00280-017-3332-7

Chicago

Yukihiro Shimizu, Hidenori Sasa, Kenichi Furuya, Hiroaki Soyama, Yusuke Aizawa, Miki Moriiwa, Masaya Nakatsuka, et al. 2017. “Is There Any Predictor for Hypersensitivity Reactions in Gynecologic Cancer Patients Treated with Paclitaxel-Based Therapy?” Cancer Chemotherapy and Pharmacology 80 (May): 65–69. doi:10.1007/s00280-017-3332-7.